期刊文献+

Faculty 1000 Spotlight

Faculty 1000 Spotlight
下载PDF
导出
摘要 1.Palliative Pancreaticoduodenectomy in Pancreatic and Periampullary Adenocarcinomas. Wang SE,Shyr YM,Su CH,Chen TH,Wu CW Pancreas.2012 Jan 26 Christos Dervenis and Dionysia Kelgiorgi,Agia Olga Hospital,Greece.F1000 Gastroenterology & Hepatology Complete tumor resection is the only curative modality for pancreatic and periampullary adenocarcinomas.However, R0 resections are not always feasible.These authors tried to clarify the role of palliative pancreaticoduodenectomy 1. Palliative Pancreaticoduodenectomy in Pancreatic and Periampullary Adenocarcinomas.Complete tumor resection is the only curative modality for pancreatic and periampullary adenocarcinomas. However, RO resections are not always feasible. These authors tried to clarify the role of palliative pancreaticoduodenectomy in pancreatic and periampullary adenocarcinoma and presented a survival benefit after pancreaticoduodenectomy despite the R status.
出处 《Clinical oncology and cancer researeh》 CAS CSCD 2012年第1期77-78,共2页
  • 相关文献

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部